BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7303701)

  • 1. [The significance of immunological investigations during radiotherapy for breast cancer (author's transl)].
    Boller B; Kärcher KH
    Wien Klin Wochenschr; 1981 Sep; 93(17):547-51. PubMed ID: 7303701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Examination of cellular immunoreaction in irradiated patients with mamma carcinoma (author's transl)].
    Stefanits K; Kuhn E; Csere T
    Radiobiol Radiother (Berl); 1977; 18(5):585-90. PubMed ID: 609721
    [No Abstract]   [Full Text] [Related]  

  • 3. Six-year study of autografts of irradiated tumour adjuvant to mastectomy and radiotherapy for cancer of the breast.
    Anderson JM
    Panminerva Med; 1973; 15(11-12):432-4. PubMed ID: 4806257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial cancer of the breast. Radiotherapy and radical surgical treatment].
    Laconi A
    Minerva Med; 1980 May; 71(19):1357-61. PubMed ID: 7383396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on non-specific immunity of breast cancer patients with postoperative irradiation (author's transl)].
    Kinoshita S
    Nihon Geka Hokan; 1979 Jul; 48(4):498-510. PubMed ID: 526089
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation versus immunity in early breast cancer.
    Turnbull AR; Turner DT; Jones BM; Wright R
    Clin Oncol; 1979 Sep; 5(3):237-44. PubMed ID: 315295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathologic and immunologic analysis for a case with carcinoma of aberrant breast of the axilla showed "abscopal effect" after the radiotherapy (author's transl)].
    Mikuriya S; Saito T; Matsuba T; Torii A; Sato O; Adachi H; Yokohari R; Matsumura K; Seto T
    Nihon Gan Chiryo Gakkai Shi; 1978 Aug; 13(4):406-13. PubMed ID: 712167
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical oncology perspective on the use of breast MR.
    Morrow M; Freedman G
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):363-78, vi. PubMed ID: 17098177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy in the curative treatment of breast cancer (author's transl)].
    Hünig R; Sauer R; Schwegler N
    Ther Umsch; 1976 Dec; 33(12):798-807. PubMed ID: 797037
    [No Abstract]   [Full Text] [Related]  

  • 12. [Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction. (author's transl)].
    Santus JP; Henocq E; Bizzini B; Bazin JC; Mogenet M; Villet R; Reynier J
    Pathol Biol (Paris); 1979 Sep; 27(7):395-401. PubMed ID: 388318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The state of immunity and the cyclic nucleotide system in the radiotherapy of breast cancer].
    Lozinskaia IN; Kalmykova IIa; Iakimova TP
    Med Radiol (Mosk); 1987 Jul; 32(7):38-42. PubMed ID: 3039286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood hemoglobin level and treatment outcome of early breast cancer.
    Henke M; Sindlinger F; Ikenberg H; Gerds T; Schumacher M
    Strahlenther Onkol; 2004 Jan; 180(1):45-51. PubMed ID: 14704844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
    Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J; Polgár C; Németh G
    Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast-conserving therapy (BCT) for early-stage breast cancer.
    Benda RK; Mendenhall NP; Lind DS; Cendan JC; Shea BF; Richardson LC; Copeland EM
    J Surg Oncol; 2004 Jan; 85(1):14-27. PubMed ID: 14696083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.